Get the Daily Brief
Latest Biotech News
Regulatory and commercial developments in respiratory immunology
Windward Bio’s IPO and asthma pipeline update drew market attention after the Swiss immune drug developer priced an initial public offering to fund late-stage work on TSLP-targeting antibodies....
Oncology biomarker strategy identifies immunotherapy-responsive colorectal subtype
A new study in Genome Medicine tied a specific genomic instability profile to immunotherapy sensitivity in microsatellite-stable colorectal cancer. Researchers reported that low chromosomal...
Digital health and pharma telehealth conflict-of-interest scrutiny
STAT+ reported that Oura’s planned acquisition of telehealth startup Counsel Health is raising potential conflict-of-interest questions for Eli Lilly, as Lilly has previously promoted Counsel on...
Clinical trial signal in stroke: saline infusion after thrombolysis
A multicenter Phase II trial reported that early abundant normal saline after intravenous thrombolysis improved 90-day functional recovery in acute ischemic stroke without increasing mortality or...
Biotherapeutic trial update: intravenous COVID protease inhibitor discontinued
A randomized clinical trial evaluating the intravenous SARS-CoV-2 protease inhibitor PF-07304814 in hospitalized COVID-19 patients ended early after serious adverse events. The premature closure...
Oncology clinical course: second-line trastuzumab deruxtecan durability in gastroesophageal cancer
A case report described durable disease control with second-line trastuzumab deruxtecan in a 63-year-old patient with HER2-positive metastatic gastroesophageal junction adenocarcinoma. After rapid...
Immunology therapeutics: ravulizumab real-world experience in myasthenia gravis
A UAE real-world case series reported clinically meaningful improvements associated with ravulizumab in patients with generalized myasthenia gravis. The report highlights benefit at the individual...
Infectious disease diagnostics: rapid carbapenemase detection directly from blood cultures
A new workflow described rapid detection of five major carbapenemases directly from positive blood cultures in under 25 minutes using the NG-TEST Blood Culture PREP Kit paired with the NG-TEST...
Drug discovery platform financing: Tolemy Bio pre-seed round and AI-in-biology pivot
Tolemy Bio detailed its path to a €1.54 million pre-seed raise, framing the financing as tied to a pivot toward software for converting biological data into forms usable by AI systems. The...
IPO and pipeline momentum in inflammation: KRAS vaccine generates T-cell responses
An investigational KRAS vaccine in a randomized Phase 2 trial generated robust T-cell responses across nearly all evaluated pancreatic cancer patients, according to the report. The study reflects...
Regulatory fast-track change at FDA
US FDA has shelved its fast-track “Commissioner’s National Priority Voucher” program aimed at cutting review timelines for drugs addressing national priorities, according to sources familiar with...
GLP-1 ecosystem deal triggers conflict-of-interest scrutiny
STAT+ reports Eli Lilly’s promotion of GLP-1 telehealth prescribing may face added conflict-of-interest complexity after Counsel Health announced it would be acquired by Oura. Counsel plans to...
Funding for next-wave GLP-1 trials through Pfizer and Blackstone
Pfizer has turned to Blackstone for up to $1.5B to bankroll clinical development of berobenatide, a monthly GLP-1 program sourced from Metsera, acquired last year. The arrangement is positioned to...
Windward Bio launches at IPO with TSLP-targeting asthma program
Windward Bio launched on the public markets after securing a $175 million IPO, starting trading under the ticker “WWB.” The Swiss immune-drug developer is advancing WIN378, an ultra-long-acting...
Cancer immunotherapy signal in KRAS vaccine Phase 2
An off-the-shelf vaccine targeting mutated KRAS generated robust immune responses in a randomized Phase 2 trial in pancreatic cancer, according to the reported results. The study found T-cell...
Regenerative medicine and tissue architecture review ties microenvironments to resistance
A comprehensive scientific review in the dataset links tissue architecture to cancer therapy resistance by synthesizing spatial multi-omics approaches. The review argues that mapping tissue...
New diagnostic acceleration for carbapenemases from blood cultures
A rapid diagnostic assay combining NG-TEST Blood Culture PREP Kit and NG-TEST CARBA 5 can detect five major carbapenemases directly from positive blood cultures in under 25 minutes, according to a...
Trial result: Ketogenic metabolic therapy feasible in severe psychiatric disorders
A randomized controlled trial found that adults with serious mental illness were able to maintain a self-prepared ketogenic diet with high adherence when supported by regular dietitian input. The...
Gene therapy durability in Crigler–Najjar syndrome
A four-year follow-up published in the New England Journal of Medicine reports that AAV8-mediated gene therapy for Crigler–Najjar syndrome sustained disease control and kept bilirubin levels in a...
Bioinformatics and clinical validation: Alleviating gaps in spatial transcriptomics analysis
Researchers introduced TranspaceR, an open-source statistical framework built to accelerate spatial transcriptomics analysis while addressing key analytical biases across large tissue datasets....